Treat and Extend Regimen of Aflibercept in the Treatment of Type 1 Choroidal Neovascularization Secondary to Chronic Central Serous Chorioretinopathy: Three-year Follow-Up

Treat and Extend Regimen of Aflibercept in the Treatment of Type 1 Choroidal Neovascularization Secondary to Chronic Central Serous Chorioretinopathy: Three-year Follow-Up

Taras B Kustryn, Oleg S Zadorozhnyy, Illia O Nasinnyk, Alla O Nevska, Kseniia V Troianovska, Nataliya V Pasyechnikova, Andrii R Korol Laser Microsurgery Department, The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine, Odesa, UkraineCorrespo...

Full description

Saved in:
Bibliographic Details
Main Authors: Kustryn TB, Zadorozhnyy OS, Nasinnyk IO, Nevska AO, Troianovska KV, Pasyechnikova NV, Korol AR
Format: Article
Language:English
Published: Dove Medical Press 2025-07-01
Series:Clinical Ophthalmology
Subjects:
chronic central serous chorioretinopathy
choroidal neovascularization
anti-vascular endothelial growth factor
aflibercept
treat-and-extend regimen
Online Access:https://www.dovepress.com/treat-and-extend-regimen-of-aflibercept-in-the-treatment-of-type-1-cho-peer-reviewed-fulltext-article-OPTH
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.dovepress.com/treat-and-extend-regimen-of-aflibercept-in-the-treatment-of-type-1-cho-peer-reviewed-fulltext-article-OPTH

Similar Items